Estimation of chicken intake using metabolomics derived markers
|Title:||Estimation of chicken intake using metabolomics derived markers||Authors:||Yin, Xiaofei
McNulty, Breige A.
Nugent, Anne P.
Gibney, Michael J.
|Permanent link:||http://hdl.handle.net/10197/9340||Date:||1-Oct-2017||Abstract:||Background: Improved assessment of meat intake using metabolomics derived markers can provide objective data and could be helpful in clarifying proposed associations between meat intake and health.Objective: The objective was to identify novel markers of chicken intake using a metabolomics approach, and use markers to determine intake in an independent cohort. Methods: Ten participants (age, 62 y; BMI, 28.25 Kg/m2) in NutriTech Food Intake Study (NCT01684917) consumed increased amounts of chicken from 88 to 290 g/day over three weeks. Urine and blood samples were analyzed by NMR and MS, respectively. Multivariate data analysis was performed to identify markers associated with chicken intake. A calibration curve was built based on dose response association using NutriTech data. Bland and Altman analysis evaluated the agreement between reported and calculated chicken intake in National Adult Nutrition Survey (NANS) cohort. Results: Multivariate data analysis of postprandial and fasting urine samples collected in NutriTech revealed good discrimination between high (290 g/day) and low (88 g/day) chicken intakes. Urinary metabolite profiles showed differences in metabolite levels between low and high chicken intakes. Examining metabolite profiles revealed guanidoacetate significantly increased from 1.47 to 3.66 mmol/L following increasing chicken intake from 88 to 290 g/day (P < 0.01). Using a calibration curve developed from NutriTech study, chicken intake was calculated in NANS, where chicken consumers had higher guanidoacetate excretion (0.70 mmol/L) than non-consumers (0.47 mmol/L) (P < 0.01). Bland and Altman analysis revealed good agreement between reported and calculated intakes with a bias of -30.2g/day. Plasma metabolite analysis demonstrated that 3-methylhistidine (3-Meth-His) was a more suitable indicator of chicken intake compared with 1-methylhistidine (1-Meth-His). Conclusions: Guanidoacetate was successfully identified and confirmed as a marker of chicken intake, and importantly its measurement in fasting urine samples could be used to determine chicken intake in a free-living population.||Funding Details:||Department of Agriculture, Food and the Marine
European Commission - Seventh Framework Programme (FP7)
European Research Council
|Type of material:||Journal Article||Publisher:||Oxford University Press||Copyright (published version):||2017 Oxford University Press||Keywords:||Metabolomics; Dietary markers; Guanidoacetate; Estimated chicken intake; 3-methylhistidine||DOI:||10.3945/jn.117.252197||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Institute of Food and Health Research Collection|
Agriculture and Food Science Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.